Get Real with Jim Weiss

From PCR to Portfolio: Christine Aylward is Funding Life Sciences

41 min · 22. april 2026
episode From PCR to Portfolio: Christine Aylward is Funding Life Sciences cover

Beskrivelse

Christine Aylward is the founder and managing partner of Magnetic Ventures, a VC built on a thesis: the future of life sciences will be technology-driven. Her bet, placed in 2018, is paying off. Her path to venture capital is unique. She started at Roche, working on PCR, arguably the most revolutionary technology at the intersection of tech and life sciences in the last century. Then she co-founded a media company with Natalie Portman. Then she launched Magnetic, raising money for companies using machine learning to transform drug discovery, clinical trials, and more. Jim and Christine get into what it really takes to spot transformative science before it's obvious, why machine learning matters more than the word AI, and why the translation from technology to product is so hard.

Kommentarer

0

Vær den første til å kommentere

Registrer deg nå og bli medlem av Get Real with Jim Weiss sitt community!

Prøv gratis

Prøv gratis i 14 dager

99 kr / Måned etter prøveperioden. · Avslutt når som helst.

  • Eksklusive podkaster
  • 20 timer lydbøker i måneden
  • Gratis podkaster

Alle episoder

52 Episoder

episode Isaac Barchas Sees The Next Biotech Boom cover

Isaac Barchas Sees The Next Biotech Boom

For decades, the biotech industry has been concentrated in a handful of coastal hubs. But according to Isaac Barchas, one of the most significant opportunities in medicine may be hiding in plain sight.In this episode of Get Real, Jim Weiss sits down with Isaac Barchas, co-founder of Arsenal Bridge Ventures, to discuss why world-class scientific research is happening far beyond Boston and Silicon Valley, and why investors have been overlooking it for years.Isaac shares Arsenal Bridge's mission to identify breakthrough discoveries emerging from universities and research institutions across America's heartland, provide the capital and leadership needed to commercialize them, and help transform promising science into life-changing therapies.Together, Jim and Isaac explore the future of biotech innovation, the challenges of building companies outside traditional venture capital hubs, and why investing in overlooked regions could be good for patients, good for business, and good for America.

10. juni 202645 min
episode Dr. Cheri Mah: Why Sleep Is the Ultimate Performance Drug cover

Dr. Cheri Mah: Why Sleep Is the Ultimate Performance Drug

Dr. Cheri Mah has spent her career proving what elite athletes are finally starting to take seriously: sleep is not optional — it’s medicine. In this episode of Get Real, the internationally recognized sleep physician and researcher joins Jim to break down how sleep drives performance, recovery, injury prevention, and mental health, both in sports and in life. They explore why chronic sleep deprivation is quietly undermining health outcomes, how teams use sleep data to gain a competitive edge, and what everyday people can learn from the way professional athletes prioritize rest. From circadian rhythm to behavior change, this conversation reframes sleep not as a luxury, but as one of the most powerful and underestimated tools we have for human performance and well‑being.

3. juni 202643 min